BioCentury | Oct 20, 2016
Product R&D

Chaperoning the DJ

...Cantabio detailed how it identified and characterized its DJ-1 pharmacological chaperones. Through a partnership with NovAliX S.A.S....
...filed Company Cantabio Pharmaceuticals Inc. Companies and Institutions Mentioned Cantabio Pharmaceuticals Inc. (OTCQB:CTBO), Sunnyvale, Calif. NovAliX S.A.S....
BioCentury | Nov 25, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...by Kyowa Hakko to a January deal to discover small molecules that modulate protein-protein interactions. NovAliX...
...as research funding and milestones. The partners declined to disclose details (see BioCentury, Jan. 21). NovAliX S.A.S....
BioCentury | Apr 22, 2013
Company News

Inventiva, NovAliX sales and marketing update

...through the IND stage. The companies declined to disclose details. Inventiva S.A.S. , Daix, France NovAliX S.A.S....
BioCentury | Mar 18, 2013
Strategy

Japan's biggest biotech

...clinical milestones and royalties on antibodies licensed by Kyowa Discovery/Preclin Jan-13 NovAliX S.A.S. Research collaboration Use NovAliX's...
BioCentury | Jan 21, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...NovAliX partnered with Kyowa to use NovAliX's Graffinity fragment-based screening technology to discover and develop small...
...Kyowa. The technology combines microarrays with surface plasmon resonance (SPR) imaging to detect compound-protein interactions. NovAliX...
...fee, as well as research funding and milestones. The companies declined to disclose further details. NovAliX S.A.S....
BioCentury | Jan 15, 2013
Company News

NovAliX, Kyowa in discovery deal

...NovAliX S.A.S. (Illkirch, France) partnered with Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) to use NovAliX's Graffinity...
...NovAliX will receive an undisclosed technology access fee, as well as research funding and milestones. NovAliX...
BioCentury | Oct 22, 2012
Company News

NovAliX management update

NovAliX S.A.S. , Illkirch, France Business: Chemistry, Supply/Service Hired: Luc Van Hijfte as CSO of drug discovery, formerly head of medicinal chemistry EU at Johnson & Johnson 's Janssen Pharmaceuticals Inc. subsidiary WIR Staff...
BioCentury | Oct 15, 2012
Company News

NovAliX, Servier deal

...Servier announced a deal with NovAliX to use NovAliX's Graffinity fragment-based screening technology to discover small...
...and research funding. NovAliX declined to disclose details. Servier could not be reached for details. NovAliX S.A.S....
BioCentury | Oct 10, 2012
Company News

NovAliX, Servier in discovery deal

...Servier (Neuilly-sur-Seine, France) announced a deal with NovAliX S.A.S. (Illkirch, France) to use NovaAliX's Graffinity fragment-based screening...
...Servier. The technology combines microarrays with surface plasmon resonance (SPR) imaging to detect compound-protein interactions. NovAliX...
BioCentury | Jan 16, 2012
Company News

NovAliX, Teijin deal

...Teijin. NovAliX will receive technology access fees and other research funding. Details were not disclosed. NovAliX S.A.S....
Items per page:
1 - 10 of 14
BioCentury | Oct 20, 2016
Product R&D

Chaperoning the DJ

...Cantabio detailed how it identified and characterized its DJ-1 pharmacological chaperones. Through a partnership with NovAliX S.A.S....
...filed Company Cantabio Pharmaceuticals Inc. Companies and Institutions Mentioned Cantabio Pharmaceuticals Inc. (OTCQB:CTBO), Sunnyvale, Calif. NovAliX S.A.S....
BioCentury | Nov 25, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...by Kyowa Hakko to a January deal to discover small molecules that modulate protein-protein interactions. NovAliX...
...as research funding and milestones. The partners declined to disclose details (see BioCentury, Jan. 21). NovAliX S.A.S....
BioCentury | Apr 22, 2013
Company News

Inventiva, NovAliX sales and marketing update

...through the IND stage. The companies declined to disclose details. Inventiva S.A.S. , Daix, France NovAliX S.A.S....
BioCentury | Mar 18, 2013
Strategy

Japan's biggest biotech

...clinical milestones and royalties on antibodies licensed by Kyowa Discovery/Preclin Jan-13 NovAliX S.A.S. Research collaboration Use NovAliX's...
BioCentury | Jan 21, 2013
Company News

NovAliX, Kyowa Hakko Kirin deal

...NovAliX partnered with Kyowa to use NovAliX's Graffinity fragment-based screening technology to discover and develop small...
...Kyowa. The technology combines microarrays with surface plasmon resonance (SPR) imaging to detect compound-protein interactions. NovAliX...
...fee, as well as research funding and milestones. The companies declined to disclose further details. NovAliX S.A.S....
BioCentury | Jan 15, 2013
Company News

NovAliX, Kyowa in discovery deal

...NovAliX S.A.S. (Illkirch, France) partnered with Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) to use NovAliX's Graffinity...
...NovAliX will receive an undisclosed technology access fee, as well as research funding and milestones. NovAliX...
BioCentury | Oct 22, 2012
Company News

NovAliX management update

NovAliX S.A.S. , Illkirch, France Business: Chemistry, Supply/Service Hired: Luc Van Hijfte as CSO of drug discovery, formerly head of medicinal chemistry EU at Johnson & Johnson 's Janssen Pharmaceuticals Inc. subsidiary WIR Staff...
BioCentury | Oct 15, 2012
Company News

NovAliX, Servier deal

...Servier announced a deal with NovAliX to use NovAliX's Graffinity fragment-based screening technology to discover small...
...and research funding. NovAliX declined to disclose details. Servier could not be reached for details. NovAliX S.A.S....
BioCentury | Oct 10, 2012
Company News

NovAliX, Servier in discovery deal

...Servier (Neuilly-sur-Seine, France) announced a deal with NovAliX S.A.S. (Illkirch, France) to use NovaAliX's Graffinity fragment-based screening...
...Servier. The technology combines microarrays with surface plasmon resonance (SPR) imaging to detect compound-protein interactions. NovAliX...
BioCentury | Jan 16, 2012
Company News

NovAliX, Teijin deal

...Teijin. NovAliX will receive technology access fees and other research funding. Details were not disclosed. NovAliX S.A.S....
Items per page:
1 - 10 of 14